Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 26:10:1030695.
doi: 10.3389/fpubh.2022.1030695. eCollection 2022.

Understanding COVID-19 vaccine hesitancy: A cross-sectional study in Malang District, Indonesia

Sujarwoto  1 , Asri Maharani  2 , Holipah  3 , Sri Andarini  3 , Rindi Ardika Melsalasa Saputri  1 , Eduwin Pakpahan  4 , Delvac Oceandy  5 , Gindo Tampubolon  6
Affiliations

Understanding COVID-19 vaccine hesitancy: A cross-sectional study in Malang District, Indonesia

Sujarwoto et al. Front Public Health. .

Abstract

Introduction: Vaccine hesitancy could undermine efforts to reduce incidence of coronavirus disease 2019 (COVID-19). Understanding COVID-19 vaccine hesitancy is crucial to tailoring strategies to increase vaccination acceptance. This study aims to investigate the prevalence of and the reasons for COVID-19 vaccine hesitancy in Malang District, Indonesia.

Methods: Data come from a cross-sectional study among individuals aged 17-85 years old (N = 3,014). Multivariate ordered logistic regression was used to identify factors associated with postponing or refusing COVID-19 vaccines. The Oxford COVID-19 vaccine hesitancy scale was used to measure vaccine hesitancy. A wide range of reasons for hesitancy, including coronavirus vaccine confidence and complacency, vaccination knowledge, trust and attitude in health workers and health providers, coronavirus conspiracy, anger reaction and need for chaos, populist views, lifestyle, and religious influence, was examined.

Results and discussion: The results show that 60.2% of the respondents were hesitant to receive the COVID-19 vaccine. Low confidence and complacency beliefs about the vaccine (OR = 1.229, 95% CI = 1.195-1.264) and more general sources of mistrust within the community, particularly regarding health providers (OR = 1.064, 95% CI = 1.026-1.102) and vaccine developers (OR = 1.054, 95% CI = 1.027-1.082), are associated with higher levels of COVID-19 vaccine hesitancy. Vaccine hesitancy is also associated with anger reactions (OR = 1.019, 95% CI = 0.998-1.040), need for chaos (OR = 1.044, 95% CI = 1.022-1.067), and populist views (OR = 1.028, 95% CI = 1.00-1.056). The findings were adjusted for socio-demographic factors, including age, sex, education, marital status, working status, type of family, household income, religious beliefs, and residency. The results suggest the need for an effective health promotion program to improve community knowledge of the COVID-19 vaccine, while effective strategies to tackle "infodemics" are needed to address hesitancy during a new vaccine introduction program.

Keywords: confidence and complacency beliefs; coronavirus; cross-sectional study; rural Indonesia; vaccine hesitancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Schoch-Spana M, Brunson EK, Long R, Ruth A, Ravi SJ, Trotochaud M, et al. . The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine. (2021) 39:6004–12. 10.1016/j.vaccine.2020.10.059 - DOI - PMC - PubMed
    1. World Health Organization . Report of the SAGE Working Group on Vaccine Hesitancy. Geneva: WHO; (2014).
    1. National Academies of Sciences Engineering Medicine . Strategies for Building Confidence in the COVID-19 Vaccines. Washington, DC: National Academies of Sciences Engineering Medicine; (2021).
    1. MacDonald NE. Vaccine hesitancy: Definition, scope, and determinants. Vaccine. (2015) 33:4161–4. 10.1016/j.vaccine.2015.04.036 - DOI - PubMed
    1. Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: An overview. Hum Vaccin Immunother. (2013) 9:1763–73. 10.4161/hv.24657 - DOI - PMC - PubMed

Publication types

Substances